Navigation Links
Surprise: Flu Vaccine Prevents Heart Attacks and Strokes; New Study on Flu Vaccine Supports Dr. Hanan Polansky’s Microcompetition Theory
Date:10/29/2013

Rochester, NY (PRWEB) October 29, 2013

Why would the flu shot decrease the risk of a heart attack or stroke? Dr. Hanan Polansky’s Theory of Microcompetition, which describes how fragments of foreign DNA (such as those found in viruses) cause most major diseases, answers this question.

A study published on October 23, 2013 in the Journal of the American Medical Association (JAMA) found that the flu virus is associated with both heart attacks and strokes. “…acute influenza infection is an independent risk factor for fatal and nonfatal cardiovascular events… Several observational studies support a potential association between the proximity of an acute respiratory infection and an increased risk of acute cardiac and cerebrovascular events (2).”

The researchers found that “those who had the influenza vaccine were 36 percent less likely to have a life-threatening heart attack, stroke, or heart failure within a year of being vaccinated, compared with those who received a placebo. Of those who received the placebo, 4.7 percent had a heart event compared with 2.9 percent who received a flu shot (1).”

The flu shot prevents infection with certain strains of the flu virus. No virus, no foreign DNA. No foreign DNA, no Microcompetition. No Microcompetition, no starved genes…and cells work as they should. Thus, there is a reduced risk of heart attack and/or stroke.

The CBCD explains: According to the Theory of Microcompetition with Foreign DNA, foreign DNA fragments, called N-boxes, cause most major diseases. When the foreign N-boxes belong to a virus, microcompetition between the viral DNA and the human DNA can lead to disease even when the virus is latent or the viral DNA is broken into pieces and cannot express proteins.

The CBCD is happy to see a new study from JAMA that is consistent with the Microcompetition with Foreign DNA Theory proposed by Dr. Hanan Polansky (3).

To learn more about Dr. Hanan Polansky’s research and the Theory of Microcompetition with Foreign DNA, visit:http://www.cbcd.net

References:

(1)    http://www.bostonglobe.com/lifestyle/health-wellness/2013/10/27/flu-vaccine-lowers-heart-attack-risk-study-finds/ur6O6TxuiIwdNa9Lj7Ap7L/story.html
(2)    http://jama.jamanetwork.com/article.aspx?articleid=1758749
(3)    http://www.cbcd.net

The CBCD is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11274873.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. New Year Surprise: My Cleaning Products Drops Bed Bug Bully's Price
2. "Sitting Ducks" No Longer: Advance Flu Warning Permits Creation of Replikins Custom Synthetic Flu Vaccine in Animals
3. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
4. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
5. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
6. Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D
7. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
8. ResearchMoz: Vaccine Production Market (Trends, Techniques, Key Players, Spending Estimates and Forecasts)
9. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
10. GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
11. AlphaVax Announces Nomination for 2012 Vaccine Industry Excellence Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative ... Inc. (PSC) , has announced that their GMP facility for cell production is ... for manufacturing. This is an important milestone for VetStem as it expands ...
(Date:5/31/2019)... ... May 30, 2019 , ... World ... Integrity on July 08-09, 2019 in Boston, MA. This peer recommended interactive workshop ... organizations. , The training will kick off with a compendial treatment of Data ...
(Date:5/15/2019)... ... ... Milton Hershey School® has named William Charles Ballough Harding ’78 the 2019 Alumnus ... is changing lives by creating solutions to global healthcare challenges through the development of ... founders – Milton and Catherine Hershey – who always hoped for Milton Hershey School ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The ... growing number of repositories being asked to store cellular products being used ... of contributors who are world leaders, who have shared their expertise in building ...
Breaking Biology Technology:
(Date:6/14/2019)... Va. (PRWEB) , ... June 14, 2019 , ... Molecular ... is estimated to be $8,760 million in 2019. Major segments that are expected ... These are all broken out and forecasted as segments in Kalorama’s The World ...
(Date:6/6/2019)... ... June 05, 2019 , ... ... in the global health and medical technology market, announced that it has selected ... / Robotics Solution” award in the 2019 MedTech Breakthrough Awards program. , ...
(Date:6/4/2019)... , ... June 04, 2019 , ... Harper was three ... X-rays revealed severe elbow dysplasia, which caused painful osteoarthritis in the joints. ... Her parents were heartbroken. , The surgical specialist, Dr. Christopher Eich of ...
Breaking Biology News(10 mins):